Jackson Purchase Medical Center

Jackson Purchase Medical Center received assistance Monday from the Kentucky National Guard. Ten guardsmen will assist with operational duties as needed from Oct. 4-13 as a part of their relief effort to help the state’s stressed healthcare infrastructure due to COVID-19. Pictured with guardsman Devon Perry are, from left, Kelsey Tynes, radiographer, and Emme Harned, X-ray student, from JPMC.

MAYFIELD – The Kentucky Cabinet for Health and Family Services (CHFS) and Kentucky Department for Public Health (KDPH) named Jackson Purchase Medical Center on Sept. 30 as a COVID-19 antibody administration center (CAAC). The hospital is one of 51 regional sites in Kentucky and one of just three located in the Purchase Area Development District. Jackson Purchase Medical Center is the closest CAAC for many people residing in the River Counties.

Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful viruses. They are specifically designed to help block the SARS-CoV-2 virus and prevent the virus from further infecting healthy cells. Administered intravenously, this innovative treatment is designed to help lessen the severity of COVID-19 in individuals who are COVID-19-positive and are at risk for developing a severe form of the disease. JPMC is offering both bamlanivimab/etesevimab and casirivimab/imdevimab combination monoclonal antibody therapies.

“We are excited to serve as a regional infusion center for the community,” said Julia Grove, chief nursing officer at JPMC. “It is another way we can provide service to the community and care for our patients in the region.” The hospital has given 452 monoclonal antibody infusions within the last 90 days.

Patients must meet specific clinical criteria to receive the therapy, including having a lab-confirmed case of COVID-19 that is mild or moderate; having underlying health conditions or more than 65 years of age; and being stable enough not to require hospitalization, among others. This therapy requires an order from the patient’s provider.

JPMC will maintain its status as a CAAC through Jan. 31, 2022, with a possible extension, if necessary. For more information about monoclonal antibody treatment now available at Jackson Purchase Medical Center, visit JacksonPurchase.com/monoclonal-antibody-treatment

Recommended for you